Evofem Biosciences, Inc.
OTC:EVFM
0.07 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -8.86 | 52.979 | -76.698 | -205.192 | -142.309 | -80.033 | -125.712 | -105.305 | -13.019 | -43.157 | -10.819 | -15.016 | -7.828 |
| Depreciation & Amortization
| 0.756 | 1.781 | 2.046 | 1.023 | 1.181 | 0.905 | 0.262 | 0.244 | 0.069 | 0.058 | 0.018 | 0.072 | 0.124 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.847 | 1.189 | 3.313 | 8.898 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0.867 | 4.728 | 6.018 | 10.578 | -15.227 | -12.673 | 3.058 | 15.261 | -4.494 | 3.382 | -0.329 | 1.394 | -1.839 |
| Accounts Receivables
| -4.094 | -4.612 | 5.323 | -5.382 | -1.067 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0.057 | 2.106 | 1.566 | -0.021 | -6.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.91 | 4.09 | 4.474 | -0.004 | 4.126 | -2.931 | 3.799 | 7.052 | 0 | 4.434 | 0.455 | 0.051 | -0.493 |
| Other Working Capital
| 5.814 | 3.144 | -5.345 | 15.985 | -12.276 | -9.742 | -0.741 | 8.209 | -4.494 | -1.051 | -0.784 | 1.343 | -1.346 |
| Other Non Cash Items
| 2.505 | -69.645 | -5.089 | 38.026 | 50.466 | 35.418 | 65.892 | 70.558 | 1.188 | 1.805 | 1.558 | 0.646 | 2.147 |
| Operating Cash Flow
| -3.885 | -8.968 | -70.41 | -146.667 | -105.889 | -56.383 | -56.5 | -19.242 | -16.255 | -37.911 | -9.572 | -12.904 | -7.396 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -0.014 | -0.004 | -0.341 | -2.939 | -2.254 | -0.164 | -0.007 | -0.006 | 0 | -0.226 | -0.018 | -0.021 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0.25 | 0.25 | 0.282 | 2.15 | 0.25 | 0.003 | 0 | 0 | 0.064 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | -8.233 | 0 | 0 | 0 | -0.2 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 8.233 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.555 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 |
| Investing Cash Flow
| -0.569 | -0.004 | -0.341 | -2.689 | 6.229 | -8.115 | 2.143 | 0.244 | 0.003 | -0.426 | -0.018 | 0.083 | 0 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -0.385 | 4.486 | 5.608 | 0 | 50 | -4.01 | 0 | 9.925 | -10.052 | 0 | 9.79 | -0.448 | 2.426 |
| Common Stock Issued
| 5 | 0 | 32.32 | 81.534 | 107.968 | 84.938 | 56.166 | -0.713 | 0.034 | 0.139 | 71.383 | 6.533 | 10.241 |
| Common Stock Repurchased
| 0 | 0 | -0.018 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | -0.157 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0.29 | 24.029 | 9.159 | -2.682 | -1.566 | -1.592 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow
| 4.615 | 4.776 | 61.939 | 90.693 | 155.286 | 79.362 | 54.417 | 9.212 | -10.019 | 0.139 | 81.174 | 6.085 | 12.667 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 0.161 | -4.196 | -8.812 | -58.663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash At End Of Period
| 0.741 | 0.58 | 4.776 | 13.588 | 71.451 | 15.875 | 1.33 | 1.211 | 11.478 | 37.749 | 75.948 | 4.364 | 11.1 |